News

Published on 30 May 2024 on Bloomberg via Yahoo Finance

Goldman Sachs Says Buy European Pharma Stocks Touting Innovation

Article preview image

(Bloomberg) -- European drugmakers that are focused on building portfolios of new medicines have gotten a nod from analysts at Goldman Sachs Group Inc.

Most Read from Bloomberg

World’s Largest Nuclear Plant Sits Idle While Energy Needs Soar‘Not Gonna Be Pretty:’ Covid-Era Homebuyers Face Huge Rate JumpWarning Signals Are Flashing for Homeowners in Texas and FloridaInsurers Sink as UnitedHealth Sees ‘Disturbance’ in MedicaidAmerican Air Fired Commercial Head After Sales Strategy Alienated Corporate Clients

Read the rest of the article
SIX.ROG price evolution
SIX.NOVN price evolution
NYSE.NVS price evolution
LSE.AZN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
3 No-Brainer Stocks to Buy in June

You're probably familiar with the old adage, "April showers bring May flowers." And you probably ...

Motley Fool via Yahoo Finance 2 Jun 2024
AstraZeneca shares target raised by Argus on new drug approvals By Investing.com

On Thursday, AstraZeneca PLC (NASDAQ:LON:AZN) shares received an updated price target from a mark...

Investing.com 30 May 2024
This Pharma Stock Is Poised to Keep Outperforming the S&P 500

AstraZeneca (NASDAQ: AZN), recognized as the world's sixth-largest pharmaceutical entity by marke...

Motley Fool via Yahoo Finance 30 May 2024
Goldman Sachs Says Buy European Pharma Stocks Touting Innovation

(Bloomberg) -- European drugmakers that are focused on building portfolios of new medicines have ...

Bloomberg via Yahoo Finance 30 May 2024
Amgen Secures FDA Nod For Rare-Disease Treatment Biosimilar Based On AstraZeneca's Drug

Amgen Secures FDA Nod For Rare-Disease Treatment Biosimilar Based On AstraZeneca's Drug Tuesday, ...

Benzinga via Yahoo Finance 29 May 2024
AstraZeneca (AZN) Falls on Failure to Meet NSCLC Study OS Goal

AstraZeneca AZN reported overall survival (OS) data from a late-stage study, which evaluated its ...

Zacks via Yahoo Finance 29 May 2024
AstraZeneca Plans to Rake in $80 Billion by 2030. Should You Buy the Stock?

AstraZeneca (NASDAQ: AZN) is embarking on a fresh business plan that will see it grow significant...

Motley Fool via Yahoo Finance 29 May 2024
AstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the Stock

As two of the world's largest and most prolific drugmakers, Pfizer (NYSE: PFE) and AstraZeneca (N...

Motley Fool via Yahoo Finance 29 May 2024
Why Is AstraZeneca Stock Trading Lower On Tuesday?

On Tuesday, AstraZeneca Plc (NASDAQ:AZN) said the survival results did not reach statistical sign...

Benzinga via AOL 29 May 2024
Why Is AstraZeneca Stock Trading Lower On Tuesday?

Why Is AstraZeneca Stock Trading Lower On Tuesday? On Tuesday, AstraZeneca Plc (NASDAQ:AZN) said ...

Benzinga via Yahoo Finance 28 May 2024

Copyright Statfolio @ 2024

Social Accounts